Management of false-positive rifampicin resistant Xpert MTB/RIF

by Natalie Beylis, Yonas Ghebrekristos, Mark Nicol
Published 2020-10-01

Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial

by Andreas Diacon, ProfPhD, Sachiko Miyahara, PhD, Rodney Dawson, PhD, Xin Sun, PhD, Evelyn Hogg, Kathleen Donahue, MA, Michael Urbanowski, PhD, Veronique De Jager, MD, Courtney V Fletcher, ProfPharmD, Richard Hafner, MD, Susan Swindells, ProfMBBS, William Bishai, ProfMD
Published 2020-06-01

Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study

by Anchi Wu, BSE, Valia T Mihaylova, PhD, Marie L Landry, ProfMD, Ellen F Foxman, ProfMD
Published 2020-10-01

COVID-19 and fungal superinfection

by Katie L Heard, Stephen Hughes, Nabeela Mughal, Luke S P Moore
Published 2020-07-01

Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses

by Zhongren Ma, Pengfei Li, Yuepeng Ji, Aqsa Ikram, Qiuwei Pan
Published 2020-08-01

Discrepancies in Xpert tuberculosis testing

by Ebrahim Variava, Tumelo Moloantoa, Neil A Martinson
Published 2020-06-01

Optimising SARS-CoV-2 pooled testing for low-resource settings

by Farhan Majid, Saad B Omer, Asim Ijaz Khwaja
Published 2020-07-01

SARS-CoV-2 cellular tropism

by Valeria Cagno
Published 2020-05-01

COVID-19 and measles: double trouble for Burundi

by Sanjeet Bagcchi
Published 2020-06-01

COVID-19-associated pulmonary aspergillosis: adding insult to injury

by Giuseppe Bruno, Claudia Fabrizio, Giovanni Battista Buccoliero
Published 2020-07-01

Re-evaluating the role of isoniazid in treatment of pulmonary tuberculosis

by Scott Heysell, Stellah Mpgama
Published 2020-06-01

COVID-19 response in central Asia

by Vijay Shankar Balakrishnan
Published 2020-11-01

Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study

by Kelvin Kai-Wang To, MD, Vincent Chi-Chung Cheng, MD, Jian-Piao Cai, BSc, Kwok-Hung Chan, PhD, Lin-Lei Chen, MPhil, Lok-Hin Wong, MPhil, Charlotte Yee-Ki Choi, BSc, Carol Ho-Yan Fong, PhD, Anthony Chin-Ki Ng, BSc, Lu Lu, BSc, Cui-Ting Luo, BSc, Jianwen Situ, MPhil, Tom Wai-Hin Chung, MRCP, Shuk-Ching Wong, MNurs, Grace See-Wai Kwan, MMedSc, Siddharth Sridhar, FRCPath, Jasper Fuk-Woo Chan, MD, Cecilia Yuen-Man Fan, FRACGP, Vivien W M Chuang, FRCPath, Kin-Hang Kok, PhD, Ivan Fan-Ngai Hung, ProfMD, Kwok-Yung Yuen, ProfMD
Published 2020-07-01

Whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational stu...

by Galo A Goig, MSc, Irving Cancino-Muñoz, MSc, Manuela Torres-Puente, PhD, Luis M Villamayor, BSc, David Navarro, ProfMD, Rafael Borrás, MD, Iñaki Comas, PhD
Published 2020-08-01

Let's not forget the basics

by The Lancet Microbe
Published 2020-07-01

Changes in clinical laboratory operations and biosafety measures to mitigate biohazard risks during the COVID-19 pandemic

by Kay Weng Choy
Published 2020-11-01

Correction to Lancet Microbe 2020; 1: e233–34

Published 2020-11-01

Increasing accessibility in COVID-19 clinical trials

by Vijay Shankar Balakrishnan
Published 2020-05-01

Host range of SARS-CoV-2 and implications for public health

by Joanne M Santini, Sarah J L Edwards
Published 2020-08-01

Management of falsepositive rifampicin resistant Xpert MTB/RIF – Authors' reply

by Jean Claude Semuto Ngabonziza, Tom Decroo, Gabriela Torrea, Patrick Migambi, Armand Van Deun, Leen Rigouts, Bouke Catherine de Jong
Published 2020-10-01